Article Details

AstraZeneca's Lokelma Gets FDA Fast-Track Designation in Patients on Chronic Hemodialysis

Retrieved on: 2021-11-17 21:46:46

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Lokelma Gets FDA Fast-Track Designation in Patients on Chronic Hemodialysis. View article details on hiswai:

Excerpt

By Colin Kellaher. AstraZeneca PLC on Wednesday said the U.S. Food and Drug Administration granted fast-track designation to its ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up